PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

Thursday, December 5, 2019

RESEARCH AND DEVELOPMENT


Newsletter

RESEARCH AND DEVELOPMENT from The Pharmaceutical Marketing Group is a regular email newsletter with news from the pharmaceutical industry

Direct to your inbox

Stay up to date with the latest appointments by subscribing to RESEARCH AND DEVELOPMENT! from The Pharmaceutical Marketing Group

View the newsletter archive

Sage Therapeutics Reports Topline Results from Pivotal Phase 3 MOUNTAIN Study of SAGE-217 in Major Depressive Disorder

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company...

Meissa Vaccines Receives FDA Clearance of IND Application for a Phase 1 Clinical Trial of MV-012-968 for Respiratory Syncytial Virus

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Meissa Vaccines (“Meissa”), a biotechnology...

NeuClone Announces Positive Results from Phase I Study of Herceptin® (Trastuzumab) Biosimilar Candidate

SYDNEY--(BUSINESS WIRE)--NeuClone Pharmaceuticals Ltd (NeuClone), a clinical-stage biopharmaceutical company...

Ra Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of Zilucoplan for IMNM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the...

AVEO Oncology Announces Lancet Oncology Publication of Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that...

Cerevance Initiates Phase 2 Trial of CVN424 for Parkinson’s Disease

BOSTON--(BUSINESS WIRE)--Cerevance, a clinical stage biopharmaceutical company advancing new...

PellePharm Completes Enrollment of Pivotal Phase 3 Clinical Trial of Patidegib Topical Gel in Patients with Gorlin Syndrome

SAN FRANCISCO--(BUSINESS WIRE)--PellePharm, Inc., a BridgeBio Pharma, Inc. (Nasdaq:...

Phathom Pharmaceuticals Announces Initiation of Pivotal Phase 3 Clinical Trial for Vonoprazan in Erosive Esophagitis

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a...